´ëÇѳúÁ¹ÁßÇÐȸ ICSU(International Conference Stroke Update) 2022 & 2nd AKJSC(Australian-Korean Joint Stroke Congress) 11/10~12(2ÀÏÂ÷) : 2022-11-11±³À°ÀÏÀÚ : 2022-11-11
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦
±³À°ÁÖÁ¦ :
ICSU(International Conference Stroke Update) 2022 & 2nd AKJSC(Australian-Korean Joint Stroke Congress) 11/10~12(2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ
´ã´çÀÚ : ±èÈñ¿µ
¿¬¶ôó : 0502-2277-1919
À̸ÞÀÏ :
stroke@stroke.or.kr ±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 9 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 350,000¿ø
ºñ°í 1. »çÀüµî·Ï(M.D Á¤È¸¿ø 20¸¸¿ø/ M.D. ¿¬È¸ºñ³³ºÎÀÚ 18¸¸¿ø/ M.D.ºñȸ¿ø 30¸¸¿ø/ M.D. ¿Ü±¹ÀÎ USD200/ Trainee 10¸¸¿ø/ Trainee ¿Ü±¹ÀÎ USD 100/ Allied Health Professionals 7¸¸¿ø/Allied Health Professionals ¿Ü±¹ÀÎ USD 70/ Accompanying Person 5¸¸¿ø/Accompanying Person ¿Ü±¹ÀÎ USD 50/One Day (Trainee & Allied Health Professionals ONLY) 2¸¸¿ø)/ One Day (Trainee & Allied Health Professionals ONLY) ¿Ü±¹ÀÎ USD 20) 2. ÇöÀåµî·Ï(M.D Á¤È¸¿ø 25¸¸¿ø/ M.D. ¿¬È¸ºñ³³ºÎÀÚ 23¸¸¿ø/ M.D.ºñȸ¿ø 35¸¸¿ø/ M.D. ¿Ü±¹ÀÎ USD250/ Trainee 13¸¸¿ø/ Trainee ¿Ü±¹ÀÎ USD 130/ Allied Health Professionals 10¸¸¿ø/Allied Health Professionals ¿Ü±¹ÀÎ USD 100/ Accompanying Person 7¸¸¿ø/Accompanying Person ¿Ü±¹ÀÎ USD 70/One Day (Trainee & Allied Health Professionals ONLY) 3¸¸¿ø)/ One Day (Trainee & Allied Health Professionals ONLY) ¿Ü±¹ÀÎ USD 30)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 09:00~09:20 VCI International cohort: Meta VCI map Nick Weaver(UMC Utrecht)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 09:20~09:40 VCI genetics Hang-Rai Kim(Dongguk Univ. Ilsan Hospital)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 09:40~10:00 Brain connectivity and VCI Jae-Sung Lim(Asan Medical Center)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 10:00~10:20 VCI clinical trials Eric Smith(Univ. of Calgary)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 10:20~10:40 Modifiable factors in VCI Minwoo Lee(Hallym Univ. Sacred Heart Hospital)
Åä·Ð 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 10:40~10:50 QnA ()
ÈÞ½Ä 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 10:50~11:10 Coffee Break ()
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 11:10~12:00 Reducing the burden of stroke: The importance of community engagement and lessons learned in the African-American community Philip B. Gorelick(Michigan State University)
Åä·Ð 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 12:00~12:10 QnA ()
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 12:10~12:30 Long-term antiplatelet therapy for stroke patients Jun Yup Kim(Seoul National University Bundang Hospital)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 12:30~12:50 A novel strategy for the lipid management of stroke patients with alirocumab Yo Han Jung(Severance Hospital)
Åä·Ð 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 12:50~13:10 QnA ()
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 13:10~13:40 Optimal treatment option for changing DAPT practices in stroke patients with ICAS Ye Rim Kim(Kangdong Sacred Heart Hospital)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 13:40~14:10 Safety profile of triflusal for secondary stroke prevention in the antiplatelet treatment Jinkwon Kim(Severance Hospital)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 14:10~14:30 Prevention of stroke recurrence in Moyamoya disease Young Seo Kim(Hanyang University Hospital)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 14:30~14:50 Acute secondary prevention: Antiplatelet therapy and beyond S. Claiborne Johnston(University of California)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 14:50~15:10 Antidiabetic drugs for stroke prevention Nam-hoon Kim(Korea University Anam Hospital)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 15:10~15:30 Factor XI inhibitor Jin Kwon Kim(Severance Hospital)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 15:30~15:50 Management in atherosclerotic vascular diseases with atrial fibrillation Young Dae Kim(Severance Hospital)
Åä·Ð 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 15:50~16:00 QnA ()
ÈÞ½Ä 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 16:00~16:20 Coffee Break ()
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 16:20~16:40 Extend time window in thrombolysis and endovascular thrombectomy Henry Ma(Monash Health)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 16:40~17:00 Outcome prediction model and futile recanalization in reperfusion therapy Hyo Suk Nam(Severance Hospital)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 17:00~17:20 Impacts of collateral circulation on endovascular thrombectomy David S. Liebeskind(UCLA Medical Center)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 17:20~17:40 Blood pressure control in endovascular thrombectomy Craig Anderson(New South Wales University)
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 17:40~18:00 Intracranial angioplasty and stenting in large vessel occlusion strokes appropriate patient selection and treatment strategy Jin Soo Lee(Ajou University Hospital)
Åä·Ð 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 18:00~18:10 QnA ()
±³À°½Ã°£ 11-11 ±×·£µå ¿öÄ¿Èú ¼¿ï ºñ½ºÅ¸È¦ 18:10~19:10 Treatment of antiplatelet agents in stroke patients Sung Wook Yu(Korea University Anam Hospital)